CRST's CSO Mika Scheinin was nominated as the Clinical Investigator of the Year 2022 CRST's CSO Mika Scheinin was nominated as the Investigator of the Year 2022 at the Clinical Trials Forum of the Pharmaceutical Information Centre/ Pharma Industry Finland.Congratulations…
Recent Posts
- LINK Medical AS acquires Finnish clinical research service company CRST Oy.
- CRST and Kancera AB signed a contract for a First-in-human trial with KAND145
- CRST has appointed Petri Vainio as the CRST’s new Chief Scientific Officer
- CRST’s scientific team contributed in a study evaluating an ASO in mild Alzheimer’s disease
- Lihavuuden lääkehoidossa kohti mullistusta
Recent Comments
No comments to show.